Technical Analysis for NLSP - NLS Pharmaceutics Ltd.

Grade Last Price % Change Price Change
D 3.23 -3.87% -0.13
NLSP closed down 3.87 percent on Wednesday, May 5, 2021, on 3 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical NLSP trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -3.87%
Fell Below 50 DMA Bearish -3.87%
MACD Bearish Centerline Cross Bearish -3.87%
Wide Bands Range Expansion -3.87%
MACD Bullish Centerline Cross Bullish -10.03%
Wide Bands Range Expansion -10.03%
NR7 Range Contraction -11.75%
Older End-of-Day Signals for NLSP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 4 hours ago
Possible NR7 about 6 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
Down 3% about 9 hours ago
Down 2 % about 9 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its two lead product candidates, include Quilience, for the treatment of excessive daytime sleepiness and cataplexy; and Nolazol, for the treatment of ADHD. NLS Pharmaceutics AG was founded in 2015 and is based in Stans, Switzerland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neurological Disorders Psychiatric Diagnosis Psychiatry Sleep Disorders Attention Deficit Hyperactivity Disorder Amphetamine Drug Therapies Narcolepsy Adhd Methylphenidate Cataplexy Childhood Psychiatric Disorders

Is NLSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.35
52 Week Low 2.06
Average Volume 3,932,983
200-Day Moving Average 0.00
50-Day Moving Average 3.53
20-Day Moving Average 3.44
10-Day Moving Average 3.55
Average True Range 0.33
ADX 15.01
+DI 20.65
-DI 22.72
Chandelier Exit (Long, 3 ATRs ) 3.07
Chandelier Exit (Short, 3 ATRs ) 3.82
Upper Bollinger Band 4.04
Lower Bollinger Band 2.84
Percent B (%b) 0.33
BandWidth 35.02
MACD Line -0.04
MACD Signal Line -0.03
MACD Histogram -0.0035
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.56
Resistance 3 (R3) 3.58 3.49 3.51
Resistance 2 (R2) 3.49 3.41 3.48 3.49
Resistance 1 (R1) 3.36 3.35 3.32 3.34 3.47
Pivot Point 3.27 3.27 3.25 3.26 3.27
Support 1 (S1) 3.14 3.19 3.10 3.12 2.99
Support 2 (S2) 3.05 3.13 3.04 2.97
Support 3 (S3) 2.92 3.05 2.96
Support 4 (S4) 2.90